Consistent with these in vitro findings, low NLRP3 mRNA expression in renal biopsies correlates with a linearly increased risk of the composite endpoint of serum creatinine doubling and progression to end-stage kidney disease in IgA nephropathy patients (176). Here, NLRP3 is linked to IgA glomerulonephritis.